CY1119704T1 - Παραγωγα τρισακχαριτη, και η χρηση τους ως ανοσοενισχυτικα - Google Patents

Παραγωγα τρισακχαριτη, και η χρηση τους ως ανοσοενισχυτικα

Info

Publication number
CY1119704T1
CY1119704T1 CY20171101340T CY171101340T CY1119704T1 CY 1119704 T1 CY1119704 T1 CY 1119704T1 CY 20171101340 T CY20171101340 T CY 20171101340T CY 171101340 T CY171101340 T CY 171101340T CY 1119704 T1 CY1119704 T1 CY 1119704T1
Authority
CY
Cyprus
Prior art keywords
trisaccharide
derivatives
immunosuppressants
trisaccharides
adjuvant compositions
Prior art date
Application number
CY20171101340T
Other languages
Greek (el)
English (en)
Inventor
Johannes Gernardus Mathias Marie Van Bree
Everardus Joannes Peter Maria Schenkelaars
Jouwert Anne Turkstra
Maria Aldegonda Jacoba Kriek
Robert Patrick Hof
Wilhelmus Martinus Maria Schaaper
Original Assignee
Immunovo B.V.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immunovo B.V. filed Critical Immunovo B.V.
Publication of CY1119704T1 publication Critical patent/CY1119704T1/el

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H13/00Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
    • C07H13/02Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids
    • C07H13/04Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids having the esterifying carboxyl radicals attached to acyclic carbon atoms
    • C07H13/06Fatty acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/39Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/107Emulsions ; Emulsion preconcentrates; Micelles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/04Immunostimulants
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00Processes for the preparation of sugar derivatives

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dispersion Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
CY20171101340T 2010-06-11 2017-12-21 Παραγωγα τρισακχαριτη, και η χρηση τους ως ανοσοενισχυτικα CY1119704T1 (el)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP10165707A EP2397484A1 (en) 2010-06-11 2010-06-11 Trisaccharide derivates, and their use as adjuvants
PCT/NL2011/050393 WO2011155822A1 (en) 2010-06-11 2011-06-03 Trisaccharide derivates, and their use as adjuvants
EP11725217.1A EP2580226B1 (en) 2010-06-11 2011-06-03 Trisaccharide derivates, and their use as adjuvants

Publications (1)

Publication Number Publication Date
CY1119704T1 true CY1119704T1 (el) 2018-06-27

Family

ID=43734127

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20171101340T CY1119704T1 (el) 2010-06-11 2017-12-21 Παραγωγα τρισακχαριτη, και η χρηση τους ως ανοσοενισχυτικα

Country Status (25)

Country Link
US (2) US9327020B2 (cg-RX-API-DMAC7.html)
EP (3) EP2397484A1 (cg-RX-API-DMAC7.html)
JP (2) JP6004586B2 (cg-RX-API-DMAC7.html)
KR (1) KR101929973B1 (cg-RX-API-DMAC7.html)
CN (1) CN103154013B (cg-RX-API-DMAC7.html)
AU (1) AU2011262606B2 (cg-RX-API-DMAC7.html)
BR (1) BR112012031440A2 (cg-RX-API-DMAC7.html)
CA (1) CA2802023C (cg-RX-API-DMAC7.html)
CY (1) CY1119704T1 (cg-RX-API-DMAC7.html)
DK (1) DK2580226T3 (cg-RX-API-DMAC7.html)
ES (1) ES2654156T3 (cg-RX-API-DMAC7.html)
HR (1) HRP20171947T1 (cg-RX-API-DMAC7.html)
HU (1) HUE035187T2 (cg-RX-API-DMAC7.html)
IL (1) IL223570A (cg-RX-API-DMAC7.html)
LT (1) LT2580226T (cg-RX-API-DMAC7.html)
MX (1) MX342946B (cg-RX-API-DMAC7.html)
NO (1) NO2580226T3 (cg-RX-API-DMAC7.html)
PL (1) PL2580226T3 (cg-RX-API-DMAC7.html)
PT (1) PT2580226T (cg-RX-API-DMAC7.html)
RS (1) RS56690B1 (cg-RX-API-DMAC7.html)
RU (1) RU2595717C2 (cg-RX-API-DMAC7.html)
SI (1) SI2580226T1 (cg-RX-API-DMAC7.html)
SM (1) SMT201700603T1 (cg-RX-API-DMAC7.html)
WO (1) WO2011155822A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA201209395B (cg-RX-API-DMAC7.html)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2397484A1 (en) * 2010-06-11 2011-12-21 Immunovo B.V. Trisaccharide derivates, and their use as adjuvants
HRP20192113T1 (hr) 2014-07-24 2020-02-21 Litevax B.V. Adjuvanti
KR20250052985A (ko) 2023-10-11 2025-04-21 세종대학교산학협력단 삼당류의 제조방법

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4232150A (en) * 1979-07-09 1980-11-04 American Cyanamid Company Oligosaccharide precursors to substituted O-α-D and O-β-D-multigalactopyranosyl and glucopyranosyl 1→4 and 1→6 galactopyranosyl 1→6α-D-glucopyranoses
GB8703128D0 (en) * 1987-02-11 1987-03-18 Donmarn Ltd Anti-scaling compounds
US5543505A (en) * 1993-03-15 1996-08-06 Sloan-Kettering Institute For Cancer Research Synthetic compounds which bind to H. pylori, and uses thereof
US6303120B1 (en) * 1994-03-15 2001-10-16 Memorial Sloan-Kettering Institute For Cancer Research Synthesis of glycoconjugates of the lewis y epitope and uses thereof
US5708163A (en) * 1994-03-15 1998-01-13 Sloan-Kettering Institute Of Cancer Research Synthesis of the breast tumor-associated antigen defined by monoclonalantibody MBRL and uses thereof
CZ297431B6 (cs) * 1994-08-04 2006-12-13 Quadrant Holdings Cambridge Limited Prostredek obsahující dodávací systém pevné dávkypro prímou aplikaci v pevné forme a zpusob jeho výroby
BE1008978A5 (fr) 1994-12-27 1996-10-01 Solvay Adjuvants pour vaccins.
US6517860B1 (en) * 1996-12-31 2003-02-11 Quadrant Holdings Cambridge, Ltd. Methods and compositions for improved bioavailability of bioactive agents for mucosal delivery
US6352722B1 (en) * 1997-12-23 2002-03-05 Quadrant Holdings Cambridge Limited Derivatized carbohydrates, compositions comprised thereof and methods of use thereof
JP3041799B1 (ja) * 1998-09-29 2000-05-15 株式会社微生物化学研究所 新規なアジュバント及びそれを用いたワクチン
EP1104767A1 (en) * 1999-11-30 2001-06-06 Stichting Dienst Landbouwkundig Onderzoek Mono- and disaccharide derivatives containing both fatty acid ester and sulfate ester groups
GB0124710D0 (en) * 2001-10-15 2001-12-05 Quadrant Healthcare Uk Ltd Therapeutic composition
ES2315777T3 (es) * 2005-12-01 2009-04-01 Wella Aktiengesellschaft Uso de poliester de di-u oligosacarido en productos para el peinado del cabello.
US9045516B2 (en) * 2007-04-16 2015-06-02 Suri Saranathan Iyer Synthetic ligands for the differentiation of closely related toxins and pathogens
WO2009140683A1 (en) * 2008-05-16 2009-11-19 Research Foundation Of The City University Of New York Living copolymer protein/peptide hybrids for biomedical applications
EP2392579B1 (en) * 2009-02-02 2016-11-23 Otsuka Chemical Co., Ltd. Low-molecular polysulfated hyaluronic acid derivative and medicine containing same
EP2397484A1 (en) * 2010-06-11 2011-12-21 Immunovo B.V. Trisaccharide derivates, and their use as adjuvants

Also Published As

Publication number Publication date
RU2013100945A (ru) 2014-07-20
CA2802023A1 (en) 2011-12-15
PT2580226T (pt) 2018-01-05
US9327020B2 (en) 2016-05-03
RU2595717C2 (ru) 2016-08-27
EP3312188A1 (en) 2018-04-25
ZA201209395B (en) 2014-05-28
LT2580226T (lt) 2018-02-26
AU2011262606B2 (en) 2016-10-27
CN103154013A (zh) 2013-06-12
JP2016216471A (ja) 2016-12-22
BR112012031440A2 (pt) 2017-04-18
JP6004586B2 (ja) 2016-10-12
US20130273082A1 (en) 2013-10-17
EP2580226A1 (en) 2013-04-17
CN103154013B (zh) 2017-03-15
EP2397484A1 (en) 2011-12-21
KR101929973B1 (ko) 2018-12-18
DK2580226T3 (en) 2018-01-08
IL223570A (en) 2017-03-30
PL2580226T3 (pl) 2018-05-30
KR20130056273A (ko) 2013-05-29
AU2011262606A1 (en) 2013-01-10
HUE035187T2 (hu) 2018-05-02
ES2654156T3 (es) 2018-02-12
MX342946B (es) 2016-10-18
US20170057987A1 (en) 2017-03-02
CA2802023C (en) 2020-07-14
WO2011155822A1 (en) 2011-12-15
SI2580226T1 (en) 2018-04-30
RS56690B1 (sr) 2018-03-30
NO2580226T3 (cg-RX-API-DMAC7.html) 2018-04-28
SMT201700603T1 (it) 2018-03-08
MX2012014422A (es) 2013-08-27
EP2580226B1 (en) 2017-11-29
JP2013528211A (ja) 2013-07-08
HRP20171947T1 (hr) 2018-02-23

Similar Documents

Publication Publication Date Title
CY1123958T1 (el) Μεθοδος παρασκευης παραγωγων και ενδιαμεσων καρβαμοϋλπυριδονης
CO7400867A2 (es) Modificador del sabor dulce
BR112012017831A2 (pt) micro-organismos produtores de ácido eicosapentaenóico, composições e ácido graxo e método de fabricação e uso dos mesmos
EP2633007A4 (en) RENEWABLE BIO-ESSENCE PRODUCTION
BR112013022397A2 (pt) vacinas combinadas com doses menores de antígeno e/ou adjuvante
CY1117956T1 (el) N3-αντικατεστημενα-n1-sulfonyl-5-fluoropyrimidinone παραγωγα
CY1116791T1 (el) 4-αρυλ-ν-φαινυλ-1,3,5-τριαζιν-αμινες που περιεχουν μια ομαδα σουλφοξιμινης
BR112015015528A8 (pt) composição e método para produzir um composto
CO6630147A2 (es) Modificador del sabor dulce
EA201890942A1 (ru) Мультивалентные вакцины с синтетическими наноносителями
BR112012023950A2 (pt) formas cristalinas de um macrolídeo, e usos dos mesmos
PH12012502352A1 (en) Hexafluoroisopropyl carbamate derivatives, their preparation and their therapeutic application
EA201791744A2 (ru) Улучшенная липидная композиция
MX375202B (es) Composiciones adyuvantes novedosas.
CY1116958T1 (el) Υποκατεστημενες τριαζολοπυριδινες και η χρηση τους ως ττκ αναστολεις
ECSP13012958A (es) Inhibidores de benzodioxano de la producción de leucotrieno.
CY1123056T1 (el) Νεα μορφη χορηγησης της ρασεκαδοτριλης
BR112013020719A2 (pt) composições de derivados de bimatoprost tipo éster e métodos
MX384120B (es) Composiciones de vacuna.
MX340147B (es) Composiciones farmacéuticas y nutracéuticas del ácido abscísico.
BR112016010862A2 (pt) Formas mórficas de ésteres de hexadeciloxipropilfosfonato, seu método de preparo e composição compreendendo a dita forma mórfica
CR20130385A (es) Cepas de saccharomyces cerevisiae aptas para la producción de levaduras de panificación osmotolerantes y que presentan una resistencia intrínseca a los ácidos orgánicos débiles, sus procedimientos de preparación y aplicaciones
CY1118514T1 (el) Μεθοδος για την παρασκευη πεμετρεξιδης και αλατος λυσινης αυτης
CY1119704T1 (el) Παραγωγα τρισακχαριτη, και η χρηση τους ως ανοσοενισχυτικα
CY1119888T1 (el) Μεθοδος για την παρασκευη ξανθοχουμολης